bijwerkingen tirzepatide Side Effects: Common & Rare Reactions Explained What to Expect Before and

Truven identified three major issues that payers are encountering with total population management as it relates to GLP-1 coverage.

This article examines their operational differences, clinical workflows, cost structures, and how they compare to compounded alternatives like PlexusDx for personalized weight management support

Seventy-two week outcomes from the SURMOUNT-5 clinical trial have shown that tirzepatide (Zepbound) met the primary endpoint and all five key secondary endpoints, demonstrating superiority, compared to semaglutide (Wegovy) across the trial.The detailed results were presented at the 32nd European Congress on Obesity (ECO) and simultaneously published in The New England Journal of Medicine.SURMOUNT-5 was a 72-week, multi-centre, randomised, open-label, Phase 3b trial evaluating the efficacy and

Learn why some patients experience increased thirst with Mounjaro or Zepbound, when to contact your doctor, and practical strategies to manage hydration during treatment.

Investigating the effects of semaglutide, a long-acting GLP-1 receptor agonist, on gut microbiota composition and metabolic profiles in patients with T2DM